Table 4 Progression-Free Survival (PFS)
From: Clinical markers of immunotherapy outcomes in advanced sarcoma
Progression-Free Survival | |
|---|---|
Category | Median PFS, in weeks (range, in weeks) |
Any ICI regimen for patients < 70yrs | 16 (11–21) |
Any ICI regimen for patients ≥ 70yrs | 42 (4–80) |
3 or more cycles; any ICI regimen | 27 (0–54) |
Less than 3 cycles; any ICI regimen | 7 (5–9) |